Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006140
Filing Date
2022-02-14
Accepted
2022-02-14 16:05:31
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3431
  Complete submission text file 0000899243-22-006140.txt   4885
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address
ARMEN GARO H (Reporting) CIK: 0000935679 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-40908 | Film No.: 22631377

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Issuer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)